SEARCH

SEARCH BY CITATION

References

  • 1
    Favaloro EJ, Wong RCW. The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours? Autoimmunity Highlights 2010;1:514.
  • 2
    Favaloro EJ, Wong R. Laboratory testing for the Antiphospholipid Syndrome: making sense of antiphospholipid antibody assays. Clin Chem Lab Med 2011;49:44761.
  • 3
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, de Groot PG, Koike T, Meroni PL, Reber G, Shoenfeld Y, Tincani A, Vlachoyiannopoulos PG, Krilis SA. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295306.
  • 4
    Willis R, Harris EN, Pierangeli SS. Pathogenesis of the antiphospholipid syndrome. Semin Thromb Hemost 2012;38:30521.
  • 5
    Pierangeli SS, Favaloro EJ, Lakos G, Meroni PL, Tincani A, Wong RC, Harris EN. Standards and reference materials for the anticardiolipin and anti-β(2)glycoprotein I assays: A report of recommendations from the APL Task Force at the 13th International Congress on Antiphospholipid Antibodies. Clin Chim Acta 2012;413:35860.
  • 6
    Favaloro EJ, Wheatland L, Jovanovich S, Roberts-Thomson P, Wong RCW. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part I – anti-cardiolipin and anti-β2-glycoprotein I antibodies. Semin Thromb Hemost 2012;38:390403.
  • 7
    Favaloro EJ. Trials and tribulations in lupus anticoagulant testing. Clin Chem Lab Med 2013;51:2536.
  • 8
    Galli M, Luciani D, Bertolini G, Barbui T. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003;101:182732.
  • 9
    Favaloro EJ, Plebani M, Lippi G. Regulation in Hemostasis and Thrombosis: Part I – In Vitro Diagnostics. Semin Thromb Hemost 2013;39. doi: 10.1055/s-0033-1336833 (in press).
  • 10
    Roubey RA. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice. Lupus 2010;19:4405.
  • 11
    Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M. De Groot PG; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2009;7:173740.
  • 12
    Favaloro EJ, Bonar R, Marsden K. Internal quality control and external quality assurance in testing for antiphospholipid antibodies: Part II – Lupus Anticoagulant. Semin Thromb Hemost 2012;38:40411.
  • 13
    Kershaw G, Suresh S, Orellana D, Nguy YM. Laboratory identification of lupus anticoagulants. Semin Thromb Hemost 2012;38:37584.
  • 14
    Tripodi A. To mix or not to mix in lupus anticoagulant testing? That is the question. Semin Thromb Hemost 2012;38:3859.
  • 15
    Pradella P, Azzarini G, Santarossa L, Caberlotto L, Bardin C, Poz A, D'Aurizio F, Giacomello R. Cooperation experience in a multicenter study to define the upper limits in a normal population for the diagnostic assessment of the functional Lupus Anticoagulant assays. Clin Chem Lab Med 2013;51:37985.
  • 16
    McGlasson DL, Fritsma GA. Comparison of Six Dilute Russell Viper Venom Time Lupus Anticoagulant Screen/Confirm Assay Kits. Semin Thromb Hemost 2013;39. doi: 10.1055/s-0033-1334865 (in press).
  • 17
    Favaloro EJ, Wong RC. Laboratory testing and identification of antiphospholipid antibodies and the antiphospholipid syndrome: a potpourri of problems, a compilation of possible solutions. Semin Thromb Hemost 2008;34:389410.
  • 18
    Galli M. Interpretation and recommended testing for antiphospholipid antibodies. Semin Thromb Hemost 2012;38:34852.
  • 19
    Pengo V, Banzato A, Bison E, Bracco A, Denas G, Ruffatti A. What Have We Learned about Antiphospholipid Syndrome from Patients and Antiphospholipid Carrier Cohorts? Semin Thromb Hemost 2012;38:3227.
  • 20
    Forastiero R, Martinuzzo M, Pombo G, Puente D, Rossi A, Celebrin L, Bonaccorso S, Aversa L. A prospective study of antibodies to β2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost 2005;3:12318.
  • 21
    Ruffatti A, Tonello M, Del Ross T, Cavazzana A, Grava C, Noventa F, Tona F, Iliceto S, Pengo V. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost 2006;96:33741.
  • 22
    de Groot PG, Urbanus RT. The future of antiphospholipid antibody testing. Semin Thromb Hemost 2012;38:41220.
  • 23
    Mameli A, Barcellona D, Vannini ML, Marongiu F. High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice. Clin Chem Lab Med 2011;49:6958.
  • 24
    Favaloro EJ, Reben R, Mohammed S, Koutts J. A clinical audit of antiphospholipid antibody testing in tertiary practice. Towards improved relevance in thrombophilia investigations?. Internal Med J 2012;42:42734.
  • 25
    Willis R, Harris EN, Pierangeli SS. Current international initiatives in antiphospholipid antibody testing. Semin Thromb Hemost 2012;38:36074.